Cleared Traditional

K152619 - Neoscope 3D - 3D Digital Video Endoscop...

K152619 is an FDA 510(k) clearance for Neoscope 3D - 3D Digital Video Endoscop..., manufactured by Prosurg, Inc.. The device is a Class 2 General & Plastic Surgery device with product code GCJ cleared through the Traditional 510(k) pathway after a 228-day FDA review.

K152619 · Prosurg, Inc. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2016
Decision
228d
Days
Class 2
Risk

K152619 is an FDA 510(k) clearance for the Neoscope 3D - 3D Digital Video Endoscopic System (Rigid/Flexible). Classified as Laparoscope, General & Plastic Surgery (product code GCJ), Class II - Special Controls.

Submitted by Prosurg, Inc. (San Jose, US). The FDA issued a Cleared decision on April 29, 2016 after a review of 228 days - an extended review cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 876.1500 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

View all Prosurg, Inc. devices

FDA 510(k) Submission Details - K152619

510(k) Number K152619 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 14, 2015
Decision Date April 29, 2016
Days to Decision 228 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
113d slower than avg
Panel avg: 115d · This submission: 228d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GCJ Device Classification - Class 2, Special Controls

Product Code GCJ Laparoscope, General & Plastic Surgery
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.1500
Definition Validated Reprocessing Instructions And Reprocessing Validation Data For This Device Type Must Be Included In A 510(k) Submission If The Device Is Reusable And Has Specific Design Features (please Refer To Table 2 Of 82 Fr 26807, Available At Https://www.gpo.gov/fdsys/pkg/fr-2017-06-09/pdf/2017-12007.pdf).
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - GCJ Laparoscope, General & Plastic Surgery

All 724
Devices cleared under the same product code (GCJ) and FDA review panel - the closest regulatory comparables to K152619.
AdTec
K160393 · Aesculap, Inc. · May 2016
Stryker SDC3 HD Information Management System with Wireless Device Control Capability
K160332 · Stryker Endoscopy · May 2016
True HD 3MOS Camera System
K161017 · Conmed Corporation · May 2016
VersaOne Optical Trocar 15mm, VersaOne Bladeless Trocar 15mm
K160230 · Covidien · Mar 2016
Arthrex Synergy UHD4 System
K153218 · Arthrex, Inc. · Feb 2016
VersaOne Bladed Trocar 5mm
K152149 · Covidien · Jan 2016